Simoa® Technology
Measure biomarkers at lower levels than ever before.
From discovery to diagnostics, Quanterix’s ultrasensitive biomarker detection is fueling breakthroughs only made possible through its unparalleled sensitivity and flexibility. Simoa® technology has delivered the gold standard for earlier biomarker detection in blood, serum or plasma, with the ability to quantify proteins that are far lower than the Level of Quantification (LoQ). Our industry-leading precision instruments, digital immunoassay technology and CLIA-certified Accelerator laboratory have supported research that advances disease understanding and management in neurology, oncology, immunology, cardiology, and infectious disease.
![Quanterix Iceberg Image](https://www.quanterix.com/wp-content/themes/quanterix-theme-2020/assets/img/iceberg.png)
HD-X™ Automated Immunoassay Analyzer
Introducing the world’s most sensitive, fully automated immunoassay platform with multiplexing and custom assay capability.
1000x
Up to 1000x greater sensitivity
4 in 1
Up to 4 biomarkers in a single assay
80+
Compatible with 80+ assays
SP-X Imaging and Analysis System™
Unleashing the power of next-generation Simoa® Planar Array technology for robust multiplex biomarker detection – even at healthy baseline levels.
1000x
Up to 1000x greater sensitivity
10 in 1
Up to 10 biomarkers in a single assay
100+
Compatible with 100+ assays
SR-X™ Biomarker Detection System
Offers researchers access to ultra-sensitive biomarker detection capabilities in a compact and affordable system.
1000x
Up to 1000x greater sensitivity
4 in 1
Up to 4 biomarkers in a single assay
30+
Compatible with 30+ assays
Ready to take your biomarker research to the next level?
request a quoteSimoa® Accelerator Laboratory
With the Simoa® Accelerator Laboratory as your pharma service technology solution of choice, you can expand the limits of biomarker exploration and dramatically accelerate the timeline to drug approvals.
request more info